150 related articles for article (PubMed ID: 1953190)
1. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers].
Sokolova TM; Nosik NN; Lopatina OA; Krylov VF
Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190
[TBL] [Abstract][Full Text] [Related]
2. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trials of recombinant gamma-interferon. Circulating interferon and the 2,5-oligoadenylate synthetase activity after intramuscular and inhalation administrations].
Sokolova TM; Lopatina OA; Nosik NN; Cheshik SG
Biull Eksp Biol Med; 1993 Jun; 115(6):633-4. PubMed ID: 7690616
[TBL] [Abstract][Full Text] [Related]
4. [The antitumor action of double-stranded interferon inducers (larifan, ridostin) and reaferon in an experiment].
Barinskiĭ IF; Posevaia TA; Lavrukhina LA; Kosiakova NP
Vopr Virusol; 1994; 39(4):179-82. PubMed ID: 7998398
[TBL] [Abstract][Full Text] [Related]
5. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
Sokolova TM; Antonov AIu; Makhov AM
Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
[TBL] [Abstract][Full Text] [Related]
6. [Demonstration of 2-5A synthetase in human circulating mononuclear cells after oral administration of an interferon inducer isolated from a fraction of Escherichia coli and Klebsiella pneumoniae].
Merlin G; Vanderhoven C; Page YM; Falcoff E
C R Acad Sci III; 1985; 300(17):619-22. PubMed ID: 3939289
[TBL] [Abstract][Full Text] [Related]
7. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.
Buffet-Janvresse C; Hovanessian AG
Proc Soc Exp Biol Med; 1984 Feb; 175(2):169-75. PubMed ID: 6198652
[TBL] [Abstract][Full Text] [Related]
8. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
9. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
Merritt JA; Borden EC; Ball LA
J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-Oligoadenylate synthetase and interferon in peripheral blood after rubella, measles, or mumps live virus vaccine.
Tilles JG; Balkwill F; Davilla J
Proc Soc Exp Biol Med; 1987 Oct; 186(1):70-4. PubMed ID: 3628253
[TBL] [Abstract][Full Text] [Related]
11. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
Merritt JA; Meltzer DM; Ball LA; Borden EC
Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
[TBL] [Abstract][Full Text] [Related]
12. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.
Hylton W; Cayley J; Dore C; Denman AM
Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470
[TBL] [Abstract][Full Text] [Related]
13. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
14. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B].
Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES
Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947
[TBL] [Abstract][Full Text] [Related]
15. Induction of blood 2',5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau.
Nakajima A; Sokawa Y
J Interferon Cytokine Res; 2002 Mar; 22(3):397-402. PubMed ID: 12034048
[TBL] [Abstract][Full Text] [Related]
16. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
[TBL] [Abstract][Full Text] [Related]
17. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
18. Induction of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells by gamma interferon.
Triozzi PL; Sedwick WD; Iland HJ; Richards RG; Laszlo J
J Biol Response Mod; 1986 Dec; 5(6):562-70. PubMed ID: 3098928
[TBL] [Abstract][Full Text] [Related]
19. Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.
Witter F; Barouki F; Griffin D; Nadler P; Woods A; Wood D; Lietman P
Clin Pharmacol Ther; 1987 Nov; 42(5):567-75. PubMed ID: 2445516
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
Chousterman S; Chousterman M; Reinert P; Thang MN
Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
